Gennex Lab. — 360° view

Gennex Lab, a company in the Pharmaceuticals industry, reported revenue of ₹40 crore and net profit of ₹4.67 crore for the June 2026 quarter.

Gennex Lab. (BSE: GENNEX) closed at ₹8.84 on 20 Nov 2026, down 38.7% over the past year. Its market capitalisation is ₹215 crore and it trades at 11.4 times earnings.

Share price
₹8.84 (20 Nov 2026)
Market cap
₹215 Cr (20 Nov 2026)
P/E
11.42 (20 Nov 2026)
Revenue
₹40 Cr (June 2026 quarter)
Net profit
₹5 Cr (June 2026 quarter)
ROCE
11.8% (FY26)
ROE
10.5% (FY26)
Book value
₹9.16 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹14.90 / ₹7.05 (20 Nov 2026)
1-year return
-38.7% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
BSE: GENNEX

Incorporated in 1995, Gennex Laboratories Ltd manufactures Bulk Drugs and Intermediaries

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.